Drug Shortage Report for GLUCAGEN
| Report ID | 146717 |
| Drug Identification Number | 02333619 |
| Brand name | GLUCAGEN |
| Common or Proper name | GLUCAGEN 1 MG |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GLUCAGON |
| Strength(s) | 1MG |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 x 1MG |
| ATC code | H04AA |
| ATC description | GLYCOGENOLYTIC HORMONES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2021-10-06 |
| Actual start date | 2021-10-06 |
| Estimated end date | 2021-10-13 |
| Actual end date | 2021-10-13 |
| Shortage status | Resolved |
| Updated date | 2021-10-14 |
| Company comments | Resolved, product is available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2021-10-06 | English | Compare |